Patients with cancer and cardiometabolic comorbidities incurred significantly higher health care costs compared to those without these conditions, with overall costs increasing since 2012.
Do cardiometabolic comorbidities increase health care costs in patients with cancer?
Cardiometabolic comorbidities significantly increase the economic burden and health care costs in patients with cancer.
Absolute Event Rate: 0% vs 0%
Health care costs for patients with cancer and preexisting cardiometabolic comorbidities have increased significantly since 2012, with a temporary decline after 2019, potentially due to the COVID-19 pandemic. Patients with cancer who had cardiometabolic comorbidities had significantly higher costs than those without these conditions.
Wu et al. (Thu,) reported a other. Patients with cancer and cardiometabolic comorbidities incurred significantly higher health care costs compared to those without these conditions, with overall costs increasing since 2012.